CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • June 3rd, 2016 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with China Biologic Products, Inc., a Delaware corporation (the “Company”), and certain selling stockholders to be named therein (the “Selling Stockholders”, providing for the public offering (the “Public Offering”) by the underwriter to be named therein (the “Underwriter”) of certain shares (the “Shares”) of the common stock of the Company, par value of $0.0001 each (the “Common Stock”).
LOCK-UP LETTERLock-Up Agreement • March 3rd, 2016 • WP X Biologics LLC • Biological products, (no disgnostic substances)
LOCK-UP LETTERLock-Up Letter • June 11th, 2015 • WP X Biologics LLC • Biological products, (no disgnostic substances)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2013 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 14, 2013, by and between China Biologic Products, Inc., a Delaware corporation (the “Company”) and WP X Biologics LLC (the “Purchaser”).
AGREEMENTEscrow Agreement • May 15th, 2013 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
This AGREEMENT (this “Agreement”) is entered into as of May 14, 2013, by and among WP X Biologics LLC, a Delaware limited liability company (“WP X”), Ms. Lin Ling Li, a Hong Kong resident with Hong Kong ID number of R330968(0) (“Ms. Li”) and Mr. Ze Qin Lin, a Hong Kong resident with Hong Kong ID number of P774319(3) and husband of Ms. Li (“Mr. Lin”). WP X, Ms. Li and Mr. Lin are hereinafter referred to as the “Parties” and each a “Party”.
JOINT FILING AGREEMENTJoint Filing Agreement • May 15th, 2013 • WP X Biologics LLC • Biological products, (no disgnostic substances)
THIS JOINT FILING AGREEMENT is entered into as of May 15, 2013, by and among the parties hereto. The undersigned hereby agree that the Statement on the amendment to the Schedule 13D with respect to the common stock, par value $0.0001 per share (the “Common Stock”) of China Biologic Products, Inc., to which this agreement is attached as an exhibit, and any amendment thereafter signed by each of the undersigned shall be (unless otherwise determined by the undersigned) filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • June 11th, 2015 • WP X Biologics LLC • Biological products, (no disgnostic substances)
THIS JOINT FILING AGREEMENT is entered into as of June 11, 2015, by and among the parties hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the common stock, par value $0.0001 per share (the “Common Stock”) of China Biologic Products, Inc., a Delaware corporation, and any amendment thereafter signed by each of the undersigned shall be (unless otherwise determined by the undersigned) filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
